Posts in Policy Updates
Drug Pricing Debate Gets an F

Last week’s Senate Finance Committee hearing on drug pricing featuring seven pharmaceutical executives earned major headlines but is not expected to result in change. The Administration’s Drug Blueprint has been met with mixed reviews as to its feasibility or potential effectiveness. Several 2020 Presidential Candidates have highlighted the issue, but no proposal has energized the public.

Read More
Concerns with the New Liver Distribution Policy

In December of 2018, the Organ Procurement and Transplantation Network (OPTN) and the United Network for Organ Sharing (UNOS) voted unanimously to approve a new liver distribution policy. Among the policy’s provisions, it moved to a national rather than regional sharing system, and to a more standardized review of exception to the patient’s MELD scores (basically a numerical representation of severity of illness).

Read More
Policy UpdatesDonna Cryer